Current research is focusing on collecting blood from families with a child who has been diagnosed with a chromosomal disorder including microdeletions in order to further develop a non-invasive prenatal screening test based on fetal DNA isolated from maternal blood.
Medically reviewed by Margaret Walsh, MD; American Board of Pediatrics
rarechromo.org. "1p36 Study Day Report."
The Ashlyn Horry Foundation. "About Us."
U.S. National Library of Medicine, National Institutes of Health. "1p36 Deletion Syndrome."